Global Portable Medical Ventilators Market size was estimated to be USD489.3 Million in 2019 and is expected to reach USD 583.47 Million by the end of 2030. It is predicted to grow at a CAGR of 9.20% from 2022 to 2030.
Portable ventilators deliver oxygen into the breathing circuit, where it can be humified by a heated humidifier or heat & moisture exchanger before delivery to the patient. These ventilators can be used for treating patients with conditions such as pneumonia, COVID 19, and during mass casualty events, among others. The increasing demand for ventilators, due to the global outbreak of COVID 19, the rapid growth of the geriatric population, and rising incidences of respiratory emergencies are the key factors that are expected to drive the market growth. Moreover, increasing incidences of chronic obstructive pulmonary disease (COPD), a rise in government expenditure on healthcare, and an increasing number of ventilator-associated pneumonia are also expected to boost market growth.
The outbreak of COVID-19, leading to increased demand for medical ventilators.
By Age Group
|Market Size||USD 583.47 Million 2030|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Mode, Interface, Age Group and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Koninklijke Philips N.V. (The Netherlands), Airon Corporation (India), Bio-Med Devices (US), Drgerwerk AG & Co. (Germany), Getinge AB (Sweden), Hamilton Medical (Switzerland), Medtronic plc (US), Percussionaire Corp. (US), ResMed (US), Smiths Group PLC (UK), Ventec Life Systems (US), Vyaire Medical, Inc. (US).|
|Key Market Opportunities||The Outbreak of COVID-19, Leading to Increased Demand for Medical Ventilators.|
|Key Market Drivers||Increasing incidences of respiratory emergencies such as asthma, emphysema, and lung cancer. Rising incidences of chronic obstructive pulmonary disease (COPD). The rapid growth of the geriatric population. Rising number of ventilator-associated pneumonia cases.|